PS Ratio
4.26
+0.03+0.71%
Wed, 12 Mar 2025 20:00:00 GMT
Summary
- As of March 13, 2025, SONN price to sales ratio is 4.26, with a rise of +0.03 (+0.71%) during the most recent trading day.
- Over the past year, SONN PS ratio has dropped by -38.51 (-90.04%).
- SONN PS ratio is now -96.69% below its all-time high of 128.65.
Performance
SONN PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
SONN PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +0.7% | +0.7% | +0.7% | - |
| 1 m1 month | -7.4% | -7.3% | -7.3% | - |
| 3 m3 months | - | -24.8% | -14.4% | - |
| 6 m6 months | - | -78.3% | +2.4% | - |
| ytdytd | -2.3% | -4.2% | -2.4% | - |
| 1 y1 year | -90.0% | -90.3% | -22.9% | +674.0% |
| 5 y5 years | - | -100.0% | - | +403.5% |
SONN PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -13.1% | 4.23 | +0.7% | |
| 3 m | 3-month | 6.01 | -29.1% | 4.23 | +0.7% |
| 6 m | 6-month | 6.01 | -29.1% | 4.23 | +0.7% |
| 1 y | 1-year | 53.69 | -92.1% | 4.23 | +0.7% |
| 3 y | 3-year | 128.65 | -96.7% | 4.23 | +0.7% |
| 5 y | 5-year | 128.65 | -96.7% | 0.38 | +1021.0% |
| alltime | all time | 128.65 | -96.7% | 0.38 | +1021.0% |
Sonnet BioTherapeutics Holdings PS Ratio History
| Date | Value |
|---|---|
| 2025 | 4.26(-2.3%) |
| 2024 | 4.36(-89.5%) |
| Date | Value |
|---|---|
| 2023 | 41.34(+16.1%) |
| 2022 | 35.61(-11.7%) |
| 2021 | 40.35 |
FAQ
- What is Sonnet BioTherapeutics Holdings price to sales ratio?
- What is the all time high PS ratio for Sonnet BioTherapeutics Holdings?
- What is SONN price to sales ratio year-to-date change?
- What is Sonnet BioTherapeutics Holdings PS ratio year-on-year change?
What is Sonnet BioTherapeutics Holdings price to sales ratio?
The current PS ratio of SONN is 4.26
What is the all time high PS ratio for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high price to sales ratio is 128.65
What is SONN price to sales ratio year-to-date change?
Sonnet BioTherapeutics Holdings price to sales ratio has changed by -0.10 (-2.29%) since the beginning of the year
What is Sonnet BioTherapeutics Holdings PS ratio year-on-year change?
Over the past year, SONN price to sales ratio has changed by -38.51 (-90.04%)